development of a second type electrode based on the silver/silver ibuprofenate pair for ibuprofen quantification in pharmaceutical samples

Clicks: 132
ID: 257271
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Ibuprofen is a widely used pharmaceutical because of its therapeutic properties; it is considered a safe medicament, thus it does not require medical prescription to be sold. However, in order to ensure consumer's health it is indispensable that the pharmaceutical industry relies on analytic methods for its quantification. Potentiometry has proven to be a successful technique using second type electrodes, which in agreement with Nernst's equation can detect anions activity. On consideration of this, this research work presents the development of a second type electrode based on the silver/silver ibuprofenate pair. This involved modifying a pure silver wire using a sodium ibuprofenate solution, to obtain the redox pair. The following analytic parameters were obtained with the aid of the modified electrode: a sensitivity of -0.049 V decade [ibuprofenate]-1, 8 µmol L-1 for the detection limit and a quantification limit of 1.2 µmol L-1. The repeatability value in terms of the relative standard deviation was 5.9%. After performing an interferences analysis using some ions and excipients, it was corroborated that there were none, thus allowing appropriate quantification on a real sample.
Reference Key
rivera-hernndezqumicadevelopment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Selene I. Rivera-Hernández;Giaan A. Álvarez-Romero;Silvia Corona-Avendaño;M. Elena Páez-Hernández;Carlos A. Galán-Vidal;Mario Romero-Romo;María Teresa Ramírez-Silva
Journal greece and rome
Year Year not found
DOI
10.21577/0100-4042.20160166
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.